Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Japan approves Roxadustat for non-dialysis anemia in chronic kidney disease Astellas Pharma and FibroGen have received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for the… bypharmanewsdailyNovember 28, 2020